Fail-safes, testing are invaluable tools
U.S. Food and Drug Administration officials and scientists are in a raee against death. It is one they must undertake in a cautious sprint. Two COVID-19 vaccines appear nearly ready to go. Before doses already on the production line can be distributed, the FDA has to approve them. Effectiveness in the 95% range is being touted by both developers, Moderna and the Pfizer-BioNTech partnership. That would be a godsend to the millions of Americans are great risk from the coronavirus. Both developers are seeking emergency authorization for distribution of the vaccines. A mechanism exists ...